Paradigm4, inc.
Paradigm4 is a tech-enabled data science company serving the Life Sciences industry, with a focus on accelerating disease understanding and drug discovery. Their core technology, incubated at MIT, offers a full-stack solution built on innovative data management and massively scalable computing capabilities. This enables partners to identify novel targets, validate AI results, and prioritize portfolios. Key offerings include REVEAL, a biomedical analytics platform designed for usability, speed, and cost-efficiency, and flexFS, a POSIX-compliant file system that reduces cloud storage and computing costs for high-throughput HPC and large-scale data analytics. Paradigm4 also provides Tech Enabled Services to accelerate client programs, with their team possessing expertise in bioinformatics, computer science, and cloud computing. Their solutions are used for applications like cohort analytics, population biobanks, and meta-analysis.
Paradigm4, inc.
Paradigm4 is a tech-enabled data science company serving the Life Sciences industry, with a focus on accelerating disease understanding and drug discovery. Their core technology, incubated at MIT, offers a full-stack solution built on innovative data management and massively scalable computing capabilities. This enables partners to identify novel targets, validate AI results, and prioritize portfolios. Key offerings include REVEAL, a biomedical analytics platform designed for usability, speed, and cost-efficiency, and flexFS, a POSIX-compliant file system that reduces cloud storage and computing costs for high-throughput HPC and large-scale data analytics. Paradigm4 also provides Tech Enabled Services to accelerate client programs, with their team possessing expertise in bioinformatics, computer science, and cloud computing. Their solutions are used for applications like cohort analytics, population biobanks, and meta-analysis.